Connect with us

Technology

Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration

Published

1 year ago

on

TUCSON, Ariz., May 8, 2025 /PRNewswire/ — The year 2025 marks a historic milestone for Critical Path Institute® (C-Path), as the organization celebrates 20 years of transforming the landscape of drug development through collaboration, regulatory science, and next-generation strategies. Founded in 2005 by Raymond Woosley, M.D., Ph.D., with the support of leaders across multiple sectors in the pharmaceutical industry and regulatory agencies, as well as visionary elected officials like Congresswomen Gabby Giffords and Marsha Blackburn (now Senator), C-Path has played a pivotal role in accelerating the development of safe and effective treatments for individuals and families worldwide.

Since its inception in Tucson, Arizona, C-Path has grown from a small team of six employees to a globally recognized leader that has generated more than 160 job opportunities to stimulate innovations that accelerate drug development and advance regulatory science through data-driven solutions.

With a unique, neutral, precompetitive model that unites industry, regulators, academia, patients and patient groups, C-Path has spearheaded groundbreaking initiatives to generate tangible solutions that have accelerated drug development in areas such as infectious disease, rare disease, neurology, and pediatrics.

See C-Path 20 Years of Innovation

“C-Path was built on the vision that no single entity can solve the challenges of the drug development process alone,” said former C-Path CEO Dr. Woosley. “Over the last 20 years, C-Path has transformed that vision into reality, bringing together experts and communities to accelerate progress and improve patient outcomes.”

A Legacy of Innovation and Impact
From its early days supporting the FDA’s Critical Path Initiative, published in 2004, to leading the first multi-stakeholder biomarker qualification efforts, C-Path has driven numerous regulatory advancements. A sample of the organization’s milestones include:

2005–2010: C-Path quickly emerged as a pioneer in accelerating drug development by launching landmark consortia and earning early regulatory endorsements for innovative safety kidney biomarkers by FDA, EMA, and PMDA.

2011–2015: C-Path gained global recognition for its trailblazing biomarker qualification work, model-informed drug development collaborations, patient-focused drug development initiatives, and international data-sharing and regulatory collaborations, leading to groundbreaking achievements, such as the first-ever clinical trial simulator endorsed by FDA and EMA (for Alzheimer’s disease).

2016–2020: C-Path expanded its disease focus—spanning rare and orphan diseases, pediatrics, as well as neurodegenerative, metabolic, and infectious conditions—while launching major data platforms, international headquarters, and initiatives with global health authorities.

2021–Present: C-Path has intensified its global impact by advancing regulatory science across diseases, expanding its partnerships, seeing pivotal drug approvals being facilitated by the tools generated through C-Path collaborations, and hosting its inaugural Global Impact Conference—culminating in its 20th anniversary celebration in 2025.

“C-Path’s work has fundamentally changed the way the industry approaches drug development,” said Wainwright Fishburn, J.D., Chair of C-Path’s Board of Directors. “Through its leadership in regulatory science, data integration, and patient-centered research, the organization has made an undeniable impact on the lives of people worldwide.”

Looking to the Future: Leading Innovation in Drug Development
Entering its third decade, C-Path stands at the intersection of human ingenuity and technological advancements, trailblazing novel solutions to realize the promise of innovations in AI, digital health, real-world data, and computational tools to turn modern drug development challenges into opportunities. As such, C-Path continues to drive smarter, faster pathways to accelerate the development of better medicines that matter.

“Our mission remains clear: to accelerate the path to new treatments by fostering innovation, scientific rigor, and collaboration,” said C-Path CEO Klaus Romero, M.D., M.S., FCP. “With a future focused on actionable precision medicine, data-driven insights, and global leadership, C-Path is poised to lead the acceleration of the next era of drug development.”

To mark its 20th anniversary, C-Path will host a series of impactful events, uniting key stakeholders to explore future opportunities in accelerating and facilitating biomedical innovation.

Kristen Swingle, M.S., C-Path President and Chief Operating Officer, reflected on the organization’s success and growth over the past two decades: “C-Path’s success is built on the dedication and expertise of our talented team. Over the last 20 years, we have transformed from a small group of visionaries to a global leader in regulatory science and drug development. Our evolution in the cutting-edge jobs we have created, and the impact they have had, is a testament to the collaborative spirit and unwavering commitment of our staff, partners, and stakeholders.”

As part of this milestone year, C-Path’s annual Global Impact Conference will take place in Washington, D.C., September 9–11, 2025. This gathering will convene global experts in drug development, regulatory science, and patient advocacy to foster collaboration and accelerate progress. We encourage members of the biomedical community to participate in shaping the future of healthcare. Registration details can be found here.

For more information on C-Path’s 20th Anniversary events and its continued impact on drug development, visit https://c-path.org/20-years-of-impact/.

About Critical Path Institute
Founded in 2005, as a public-private partnership in response to the FDA’s Critical Path Initiative, Critical Path Institute® (C-Path) celebrates its 20th anniversary as a vital, independent, nonprofit. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is located in Tucson, Arizona and C-Path’s Europe subsidiary is headquartered in Amsterdam, Netherlands. For more information, visit c-path.org.

 Media Contacts:

Roxan Triolo Olivas
C-Path
520.954.1634
rolivas@c-path.org

Kissy Black
C-Path
615.310.1894
kblack@c-path.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/critical-path-institute-celebrates-20-years-of-advancing-drug-development-through-innovation-and-collaboration-302450430.html

SOURCE Critical Path Institute

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Pope Leo XIV embraces paediatric patients at CNAO in Pavia

Published

2 hours ago

on

June 20, 2026

By

PAVIA, Italy, June 20, 2026 /PRNewswire/ — The National Center for Oncological Hadrontherapy (CNAO) served as the first stop today during Pope Leo XIV’s pastoral visit to the city of Pavia. His choice to begin his journey at this center reflects a profound commitment to fostering meaningful dialogue between advanced scientific progress and the alleviation of human suffering.

CNAO President Gianluca Vago and General Manager Sandro Rossi received His Holiness, illustrating the center’s distinctive capabilities. CNAO stands out as a unique reality in Italy, remaining one of the very few facilities worldwide capable of delivering hadrontherapy using both protons and carbon ions. The technological core of the facility is its synchrotron, a subatomic particle accelerator that generates ultra-high-precision beams to treat complex, inoperable and radioresistant tumours. This cutting-edge technology allows for the targeted eradication of diseased cells while meticulously preserving surrounding healthy tissues, drastically improving patients’ survival and quality of life.

Furthermore, CNAO is expanding its capabilities as a premier multi-center utilizing new ion species, like Helium, later Oxygen and Neon. Soon, treatments will incorporate the Leo Cancer Care upright positioning and imaging system. The immediate future also includes beginning therapies with a Hitachi dedicated proton accelerator and gantry and a BNCT system for metastatic diseases, equipped with an electrostatic accelerator produced by TAE Life Science. With these new technologies, CNAO will become one of the most technologically advanced center in the world.

To date, over six thousand individuals, including approximately three hundred children and adolescents, have benefited from these life-saving treatments.

During his visit, the Pope engaged with CNAO’s Board of Directors, a collaborative body uniting national universities, clinical institutions, and research centers. He also extended his heartfelt greetings to the two hundred employees of the center. These doctors, physicists, engineers, and researchers tirelessly operate the advanced technologies in the service of oncology patients.

The emotional pinnacle of the day was the Holy Father’s private gathering with a delegation of young children who underwent treatment. The paediatric patients and their families shared a deeply touching moment of closeness, receiving the Pope’s comforting embrace.

“The visit of Pope Leo XIV honours us and represents a moment of extraordinary human value”, stated CNAO President Gianluca Vago. “In his encyclical Magnifica Humanitas, the Holy Father emphasizes the necessity of a science that constantly safeguards the centrality of the person and directs technology toward the common good. In a time marked by global tensions, CNAO testifies daily how the incredible power of the atom can be used not to destroy, but to heal. The particle beams we utilize against disease are, symbolically, Rays of Hope, sharing and supporting the IAEA project bearing this name. The embrace the Holy Father reserved for our children reminds us that scientific research finds its most authentic purpose when it encounters listening, compassion, and hope”.

Photo – https://mma.prnewswire.com/media/2997869/Papa_al_Cnao_crediti_Andrea_Perotti.jpg
Logo – https://mma.prnewswire.com/media/2997643/CNAO_Logo.jpg

 

 

View original content:https://www.prnewswire.co.uk/news-releases/pope-leo-xiv-embraces-paediatric-patients-at-cnao-in-pavia-302805799.html

Continue Reading

Technology

HelloNation Article Examines Full Coverage Auto Insurance With Insurance Expert Ben Buenzow

Published

4 hours ago

on

June 20, 2026

By

The article explains what full coverage auto insurance typically includes, what it excludes, and how coverage limits affect Iowa drivers.

URBANDALE, Iowa, June 20, 2026 /PRNewswire/ — What does full coverage auto insurance actually include for drivers in Iowa? That question is answered in a HelloNation article featuring insights from Insurance Expert Ben Buenzow of Buenzow Insurance Group in Urbandale, Iowa.

The HelloNation article explains that full coverage auto insurance is a commonly used phrase that many drivers misunderstand. While the term suggests broad protection, it usually refers to a combination of liability coverage, collision coverage, and comprehensive coverage within an insurance policy. Understanding what these components cover helps drivers avoid gaps in protection and unexpected costs after an accident.

Liability coverage forms the legal foundation of auto insurance in Iowa. The article explains that liability coverage pays for injuries or property damage that a driver causes to others in an accident. State law requires Iowa drivers to carry minimum liability limits, and full coverage auto insurance policies include at least those required limits. However, liability coverage does not pay for damage to the driver’s own vehicle, which is why additional protection is often necessary.

Collision coverage is the part of a policy that helps pay for damage to the driver’s own vehicle after an accident. The HelloNation article notes that collision coverage applies when a vehicle hits another car, a guardrail, or a stationary object. In most cases, the insurer pays the actual cash value of the vehicle or the repair cost minus the policy’s deductible. Insurance Expert Ben Buenzow is featured in the article as a source of insights on how deductibles influence both insurance premiums and out-of-pocket costs during a claim.

Comprehensive coverage addresses a different type of risk. According to the article, comprehensive coverage protects against damage caused by events other than collisions. This includes hail, theft, vandalism, fire, falling objects, or animal-related incidents. For Iowa drivers, weather-related risks such as hailstorms can make comprehensive coverage an important part of a full coverage auto insurance policy.

The HelloNation article also explains that deductibles apply to both collision coverage and comprehensive coverage. The deductible is the amount the policyholder must pay before insurance coverage begins. Drivers can often choose higher or lower deductibles depending on their financial preferences. Higher deductibles typically reduce premium costs but increase the amount paid out of pocket if damage occurs.

Another important takeaway from the article is what full coverage auto insurance does not automatically include. Standard policies usually do not provide roadside assistance, rental reimbursement, or gap coverage unless these features are added separately. The article explains that roadside assistance covers towing or emergency services, while rental reimbursement helps cover the cost of a temporary vehicle during repairs.

Gap coverage is another optional feature highlighted in the article. It is often recommended for drivers who finance or lease newer vehicles. Gap coverage pays the difference between the remaining loan balance and the vehicle’s actual cash value if it is declared a total loss after an accident.

The article also discusses the importance of understanding coverage limits within an insurance policy. Coverage limits determine the maximum amount an insurer will pay for a covered loss. If damage or liability exceeds those limits, the driver may be responsible for the remaining costs. Reviewing coverage limits carefully helps drivers ensure their policy reflects both the value of their vehicle and their financial risk.

Insurance Expert Ben Buenzow is again referenced in the article as part of a broader discussion about how drivers can make informed decisions about Iowa car insurance. The article encourages drivers to evaluate deductibles, coverage limits, and optional protections based on their individual needs.

The HelloNation article concludes by emphasizing that drivers should periodically review their insurance policy. Changes in vehicle value, financial circumstances, and driving habits can all affect the appropriate level of coverage. Understanding the components of full coverage auto insurance helps drivers maintain adequate protection and prepare for unexpected events on the road.

Iowa Auto Insurance: What Full Coverage Includes and Excludes features insights from Ben Buenzow, Insurance Expert of Urbandale, Iowa, in HelloNation.

About HelloNation
HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hellonation-article-examines-full-coverage-auto-insurance-with-insurance-expert-ben-buenzow-302805432.html

SOURCE HelloNation

Continue Reading

Technology

HelloNation Clarifies Ohio Waiver Waiting List Classifications For Adults With Disabilities, Featuring Home Healthcare Expert Kellan Roberts Of Canton, Ohio

Published

4 hours ago

on

June 20, 2026

By

The article explains immediate need and current need categories and how families can navigate Medicaid waiver programs.

CANTON, Ohio, June 20, 2026 /PRNewswire/ — What should families of developmental disabilities know about the Ohio waiver waiting list and how immediate need and current need classifications affect access to services? HelloNation provides guidance in an article featuring insights from Home Healthcare Expert Kellan Roberts of R House Home Health Care Services in Canton, Ohio.

The HelloNation article explains that the Ohio waiver waiting list exists because demand for Medicaid waiver programs often exceeds available funding. To manage this gap, counties use service prioritization categories to determine who receives services first. Understanding how these classifications work helps families plan more effectively and reduce uncertainty.

According to the article, immediate need generally refers to adults with developmental disabilities who cannot safely remain at home without prompt services. This may include individuals who have lost caregiver support or experienced a sudden health crisis. In contrast, the current need applies to individuals who require support but whose living situations remain stable enough to wait for waiver programs to become available.

The article emphasizes that documentation plays a critical role in determining placement on the Ohio waiver waiting list. Families must provide medical records, assessments, and supporting information that clearly demonstrate the level of need. Counties review this documentation carefully and may conduct interviews or home visits to confirm circumstances before assigning a classification.

Accurate and updated records are described as essential for proper service prioritization. Needs can change over time, and families are encouraged to notify county offices if circumstances worsen. A person initially categorized under current need may later qualify as immediate need if conditions shift. Staying engaged ensures that updated information is considered during periodic reviews.

While waiting for Medicaid waiver programs to begin, families may need to explore temporary supports. The article notes that personal care services, homemaker assistance, and community programs can help adults with disabilities maintain daily routines and independent living during the waiting period. These interim solutions provide structure and stability while long-term services are pending.

Family planning is highlighted as an important part of navigating the process. Understanding how waiver programs operate, what services they provide, and how classifications are reviewed allows families to make informed decisions. Planning ahead also reduces stress and prepares adults with disabilities for a smoother transition once services are approved.

The article further explains that service prioritization is not static. Counties regularly reassess waiting lists and adjust classifications based on updated information or changes in resources. Families benefit from understanding review timelines and maintaining open communication with county representatives.

Medicaid waiver programs offer a range of supports, including personal care, homemaker services, transportation, and community engagement. The HelloNation article advises families to consider how these services align with long-term goals related to independence, skill development, and community participation. Preparing in advance allows adults with disabilities to transition into services more efficiently when their turn arrives.

Ultimately, the article presents the Ohio waiver waiting list as a system that requires preparation, patience, and active participation. By understanding immediate need and current need classifications, maintaining proper documentation, and staying involved throughout the review process, families can better advocate for timely care and ensure continued safety and stability.

Immediate vs Current Need: How to Navigate the Ohio Waiver Waiting List features insights from Kellan Roberts, Home Healthcare Expert of Canton, Ohio, in HelloNation.

About HelloNation
HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hellonation-clarifies-ohio-waiver-waiting-list-classifications-for-adults-with-disabilities-featuring-home-healthcare-expert-kellan-roberts-of-canton-ohio-302805455.html

SOURCE HelloNation

Continue Reading

Trending